| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.51B | +12.0% | +9.8% |
| Cost of Revenue | $674.2M | +3.2% | +5.5% |
| R&D Expense | $453.4M | +2.3% | +9.8% |
| SG&A Expense | $251.3M | +0.5% | +13.7% |
| Operating Income | -$128.4M | +50.6% | +25.9% |
| Pre-tax Income | -$103.0M | +59.6% | +28.9% |
| Income Tax | $510K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $953.3M | +3.0% | -1.2% |
| Short-term Investments | $2.04B | +3.7% | -8.4% |
| Accounts Receivable | $1.25B | +7.1% | +4.4% |
| Current Assets | $4.48B | +4.5% | -2.4% |
| Total Assets | $7.58B | +2.4% | -0.2% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $146.5M | +65.5% | +26.4% |
| Capital Expenditures | $53.0M | -18.0% | +20.4% |
| Investing Cash Flow | -$107.9M | -150.1% | +51.6% |
| Financing Cash Flow | -$12.0M | +95.9% | -216.6% |
| Free Cash Flow | $93.4M | +292.7% | +30.1% |
| -93.3% |
| -93.9% |
| Net Income | -$103.5M | +60.6% | +32.4% |
| EPS (Basic) | -$0.06 | +62.5% | +33.3% |
| EPS (Diluted) | -$0.06 | +62.5% | +33.3% |
| $1.22B |
| +10.7% |
| +7.4% |
| Long-term Debt | $3.54B | -1.1% | -2.8% |
| Total Liabilities | $5.35B | +0.4% | -0.6% |
| Stockholders' Equity | $2.23B | +7.6% | +0.8% |